Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis
MT Clunes, RC Boucher - Current opinion in pharmacology, 2008 - Elsevier
Although cystic fibrosis (CF) patients display multiorgan dysfunction (eg pancreas, gut, and
lung) it is lung disease that is the leading cause of premature death in these patients. CF …
lung) it is lung disease that is the leading cause of premature death in these patients. CF …
Inhaled mannitol improves lung function in cystic fibrosis
A Jaques, E Daviskas, JA Turton, K McKay, P Cooper… - Chest, 2008 - Elsevier
Background The airways in patients with cystic fibrosis (CF) are characterized by the
accumulation of tenacious, dehydrated mucus that is a precursor for chronic infection …
accumulation of tenacious, dehydrated mucus that is a precursor for chronic infection …
Defining an inhibitory domain in the α-subunit of the epithelial sodium channel
MD Carattino, CJ Passero, CA Steren… - American Journal …, 2008 - journals.physiology.org
Epithelial sodium channels (ENaC) are processed by proteases as they transit the
biosynthetic pathway. We recently observed that furin-dependent processing of the α …
biosynthetic pathway. We recently observed that furin-dependent processing of the α …
Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis
EP Dellon, SH Donaldson, R Johnson… - Pediatric …, 2008 - Wiley Online Library
Background Inhaled hypertonic saline (HS) improves lung function and decreases
pulmonary exacerbations in older patients with cystic fibrosis (CF). Initiating therapies in …
pulmonary exacerbations in older patients with cystic fibrosis (CF). Initiating therapies in …
Cystic fibrosis: a review of pulmonary and nutritional therapies
Cystic fibrosis (CF) is an autosomal recessive disease caused by a defect in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene. CFTR is expressed in the …
fibrosis transmembrane conductance regulator (CFTR) gene. CFTR is expressed in the …
Efetividade e segurança da nebulização com solução salina hipertônica em pacientes com doença pulmonar obstrutiva crônica: ensaio clínico randomizado
SR Valderramas - 2008 - bdtd.ibict.br
Introdução: O uso de solução salina hipertônica já foi documentado em DPOC como um
método de broncoprovocação e indução de escarro, mas estudos que avaliem outros …
método de broncoprovocação e indução de escarro, mas estudos que avaliem outros …
[引用][C] The Effect Of Residential Location On The Lung Function & Body Mass Index Of Cystic Fibrosis Sufferers
A Hanson